340bemployed.org

Your Free Source for 340B News and Commentary

  • Home
  • About Us
  • Employers
  • Job Seekers
  • Advertise
  • 340B Health

Report: Patient Groups Mum on High Drug Costs


 

Print Article

February 23, 2017—Big Pharma pours so much money into patient advocacy groups that the dough renders them mute on the drug price issue, according to a trenchant piece in USAToday.

“The National Patient Advocate Foundation receives 60 percent of its $2 million budget from the pharmaceutical industry, while the Colon Cancer Alliance gets 15 percent of its $1.2 million budget,” says the publication. “Several other groups get up to 20 percent of their revenue from drug companies.”

And surprise, surprise: NPAF and CCA have been harsh critics of the 340B drug discount program.

We’ve highlighted these conflicts of interest before but the alarm can’t be sounded often enough. While there are natural reasons drug companies and disease advocacy groups work closely, the enormous money spent gives the industry a convenient check on organized patient criticism on nearly any issue.

That investment has paid off handsomely in the drug pricing fight now gripping Washington. Currently, insurance companies and health providers are facing off against Big Pharma with hardly a patient in sight. Some patient groups put drug costs far down the list of priorities. “NPAF’s 2015 data on calls from about 14,000 cancer patients shows transportation was the top concern, followed by hospital and doctor co-pays, rent and mortgages and then prescription co-pays,” says the USAToday story.

Such is the power of the drug industry, even as it stumbles consistently in its effort to counter public ire over astronomical prices.

For a more realistic view of the situation, a new report in the Journal Cancer indicates some patients are cutting corners on their own treatment to avoid high drug bills.

340B helps needy patients avoid these impossible situations. Each day, thousands of Americans receive free or discounted medications and clinical services thanks to the program.

Recent Articles

  • HRSA Still Plans to Start Enforcing New 340B Regulation on April 1
  • Big Pharma Plays the Blame Game on Drug Prices
  • Report: Patient Groups Mum on High Drug Costs

Follow us on Twitter

340B Health Follow

340B Health is the leading advocate & resource for hospitals that serve their communities by participating in the 340B drug pricing program. #Protect340B

340BHealth
340bhealth 340B Health @340bhealth ·
21h

#340B is funding an important #healthcare program in Alabama for patients living with #HIV who are without stable housing. Learn more: https://bit.ly/3p8tb5Z #Protect340B #SDOH

Reply on Twitter 1558847917829591042 Retweet on Twitter 1558847917829591042 1 Like on Twitter 1558847917829591042 Twitter 1558847917829591042
340bhealth 340B Health @340bhealth ·
13 Aug

Some of the youngest patients benefit from #340B. Read how safety-net hospitals have customized how they use their program savings to meet the needs of children in their community. https://bit.ly/3dn96q2 #ChildrensHealth #Protect340B

Reply on Twitter 1558526550022037504 Retweet on Twitter 1558526550022037504 1 Like on Twitter 1558526550022037504 4 Twitter 1558526550022037504
340bhealth 340B Health @340bhealth ·
12 Aug

Did you know the percentage of Medicare patients treated in #340B hospitals who identify as Black is 69% higher than at non-340B hospitals?
340B hospitals are meeting their mission to provide #healthcare to historically underserved patients. https://bit.ly/3bPAf4A #Protect340B

Reply on Twitter 1558117281728798721 Retweet on Twitter 1558117281728798721 3 Like on Twitter 1558117281728798721 6 Twitter 1558117281728798721
Load More

RSS 340B Informed

  • The End Appears Near for Medicare Cuts to 340B Hospitals
  • Faces of 340B: Community Pharmacy Restrictions Mean Worse Health Outcomes
  • 340B Hospitals on the Front Lines of the Fight for Health Equity

Copyright © 2022 · 340B Health